vs
Side-by-side financial comparison of FutureFuel Corp. (FF) and NORTECH SYSTEMS INC (NSYS). Click either name above to swap in a different company.
NORTECH SYSTEMS INC is the larger business by last-quarter revenue ($30.3M vs $19.8M, roughly 1.5× FutureFuel Corp.). NORTECH SYSTEMS INC runs the higher net margin — 3.0% vs -60.5%, a 63.5% gap on every dollar of revenue. On growth, NORTECH SYSTEMS INC posted the faster year-over-year revenue change (5.9% vs -67.7%). NORTECH SYSTEMS INC produced more free cash flow last quarter ($5.5M vs $-29.9M). Over the past eight quarters, NORTECH SYSTEMS INC's revenue compounded faster (-5.9% CAGR vs -41.7%).
FutureFuel Corporation is a developer and producer of chemicals and biofuels. It is listed on the New York Stock Exchange, with symbol FF.
Nortech Systems Inc is a global electronics manufacturing services provider. It delivers end-to-end solutions covering product design, prototyping, full-scale production, and supply chain management for clients operating in medical technology, industrial automation, aerospace and defense, and transportation sectors. It specializes in high-reliability, regulatory-compliant electronic components and assemblies tailored to strict industry standards.
FF vs NSYS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.8M | $30.3M |
| Net Profit | $-12.0M | $897.0K |
| Gross Margin | -46.7% | 16.7% |
| Operating Margin | -62.9% | 3.0% |
| Net Margin | -60.5% | 3.0% |
| Revenue YoY | -67.7% | 5.9% |
| Net Profit YoY | -529.4% | 160.7% |
| EPS (diluted) | $-0.28 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.8M | $30.3M | ||
| Q3 25 | $22.7M | $30.5M | ||
| Q2 25 | $35.7M | $30.7M | ||
| Q1 25 | $17.5M | $26.9M | ||
| Q4 24 | $61.5M | $28.6M | ||
| Q3 24 | $51.1M | $31.4M | ||
| Q2 24 | $72.4M | $33.9M | ||
| Q1 24 | $58.3M | $34.2M |
| Q4 25 | $-12.0M | $897.0K | ||
| Q3 25 | $-9.3M | $-146.0K | ||
| Q2 25 | $-10.4M | $313.0K | ||
| Q1 25 | $-17.6M | $-1.3M | ||
| Q4 24 | $2.8M | $-1.5M | ||
| Q3 24 | $-1.2M | $-739.0K | ||
| Q2 24 | $9.6M | $157.0K | ||
| Q1 24 | $4.3M | $765.0K |
| Q4 25 | -46.7% | 16.7% | ||
| Q3 25 | -30.1% | 16.5% | ||
| Q2 25 | -24.6% | 15.8% | ||
| Q1 25 | -83.0% | 11.4% | ||
| Q4 24 | 9.1% | 9.9% | ||
| Q3 24 | 0.7% | 12.2% | ||
| Q2 24 | 12.0% | 13.6% | ||
| Q1 24 | 8.6% | 15.9% |
| Q4 25 | -62.9% | 3.0% | ||
| Q3 25 | -42.9% | 3.1% | ||
| Q2 25 | -33.4% | 2.4% | ||
| Q1 25 | -107.4% | -6.0% | ||
| Q4 24 | 2.6% | -4.3% | ||
| Q3 24 | -5.6% | -1.5% | ||
| Q2 24 | 7.5% | 1.0% | ||
| Q1 24 | 3.8% | 3.4% |
| Q4 25 | -60.5% | 3.0% | ||
| Q3 25 | -41.1% | -0.5% | ||
| Q2 25 | -29.2% | 1.0% | ||
| Q1 25 | -100.6% | -4.9% | ||
| Q4 24 | 4.5% | -5.2% | ||
| Q3 24 | -2.3% | -2.4% | ||
| Q2 24 | 13.2% | 0.5% | ||
| Q1 24 | 7.4% | 2.2% |
| Q4 25 | $-0.28 | $0.32 | ||
| Q3 25 | $-0.21 | $-0.05 | ||
| Q2 25 | $-0.24 | $0.12 | ||
| Q1 25 | $-0.40 | $-0.48 | ||
| Q4 24 | $0.06 | $-0.51 | ||
| Q3 24 | $-0.03 | $-0.27 | ||
| Q2 24 | $0.22 | $0.05 | ||
| Q1 24 | $0.10 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $51.3M | $1.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $154.7M | $34.5M |
| Total Assets | $192.2M | $71.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.3M | $1.7M | ||
| Q3 25 | $85.6M | $1.3M | ||
| Q2 25 | $95.2M | $652.0K | ||
| Q1 25 | $97.1M | $1.2M | ||
| Q4 24 | $109.5M | $916.0K | ||
| Q3 24 | $133.4M | $1.2M | ||
| Q2 24 | $115.1M | $1.5M | ||
| Q1 24 | $201.1M | $4.0M |
| Q4 25 | $154.7M | $34.5M | ||
| Q3 25 | $169.1M | $33.4M | ||
| Q2 25 | $178.2M | $33.4M | ||
| Q1 25 | $188.4M | $32.8M | ||
| Q4 24 | $205.8M | $34.0M | ||
| Q3 24 | $213.3M | $35.7M | ||
| Q2 24 | $214.4M | $36.1M | ||
| Q1 24 | $204.8M | $36.0M |
| Q4 25 | $192.2M | $71.9M | ||
| Q3 25 | $203.5M | $74.8M | ||
| Q2 25 | $218.2M | $74.8M | ||
| Q1 25 | $227.7M | $73.5M | ||
| Q4 24 | $247.7M | $72.4M | ||
| Q3 24 | $256.5M | $77.0M | ||
| Q2 24 | $261.2M | $76.3M | ||
| Q1 24 | $365.4M | $75.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-27.4M | $5.6M |
| Free Cash FlowOCF − Capex | $-29.9M | $5.5M |
| FCF MarginFCF / Revenue | -150.5% | 18.0% |
| Capex IntensityCapex / Revenue | 12.2% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 6.25× |
| TTM Free Cash FlowTrailing 4 quarters | $-46.0M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-27.4M | $5.6M | ||
| Q3 25 | $-1.1M | $-92.0K | ||
| Q2 25 | $5.2M | $157.0K | ||
| Q1 25 | $-5.4M | $-2.9M | ||
| Q4 24 | $-16.6M | $793.0K | ||
| Q3 24 | $25.8M | $-1.6M | ||
| Q2 24 | $27.8M | $-4.3M | ||
| Q1 24 | $-12.2M | $2.8M |
| Q4 25 | $-29.9M | $5.5M | ||
| Q3 25 | $-6.5M | $-242.0K | ||
| Q2 25 | $-263.0K | $58.0K | ||
| Q1 25 | $-9.4M | $-3.2M | ||
| Q4 24 | $-20.7M | $503.0K | ||
| Q3 24 | $20.5M | $-1.6M | ||
| Q2 24 | $24.8M | $-4.6M | ||
| Q1 24 | $-14.5M | $2.1M |
| Q4 25 | -150.5% | 18.0% | ||
| Q3 25 | -28.5% | -0.8% | ||
| Q2 25 | -0.7% | 0.2% | ||
| Q1 25 | -53.6% | -11.9% | ||
| Q4 24 | -33.6% | 1.8% | ||
| Q3 24 | 40.1% | -5.2% | ||
| Q2 24 | 34.3% | -13.5% | ||
| Q1 24 | -24.9% | 6.1% |
| Q4 25 | 12.2% | 0.5% | ||
| Q3 25 | 23.5% | 0.5% | ||
| Q2 25 | 15.3% | 0.3% | ||
| Q1 25 | 22.8% | 1.0% | ||
| Q4 24 | 6.6% | 1.0% | ||
| Q3 24 | 10.4% | 0.1% | ||
| Q2 24 | 4.1% | 0.8% | ||
| Q1 24 | 3.9% | 2.2% |
| Q4 25 | — | 6.25× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | — | ||
| Q4 24 | -5.94× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.90× | -27.30× | ||
| Q1 24 | -2.82× | 3.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FF
| Chemicals | $18.0M | 91% |
| Biofuels | $1.8M | 9% |
NSYS
| Medical Imaging | $11.4M | 37% |
| Medical Device | $8.0M | 26% |
| Industrial | $7.3M | 24% |
| Aerospace And Defense | $3.7M | 12% |
